Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Health Care Startup Investors in United Kingdom in December 2024

Last updated: Dec 2024 A list of 50 angel investors and VC (Venture Capital) funds that invest in Health care startups based in United kingdom. We rank investors based on the number of investments they made in Health care companies from United kingdom. We update this investor list every month.

Top 50 Health Care Startup Investors in United Kingdom in December 2024

Investor	Health Care United Kingdom investments
UK Innovation & Science Seed Fund	61
Parkwalk Advisors	59
Oxford Science Enterprises	46
Oxford Technology Management	45
Development Bank of Wales	45
Scottish Enterprise	44
Deepbridge Capital	44
Mercia Fund Managers	40
Scottish Investment Bank	38
AlbionVC	37
Catapult Ventures	37
Business Growth Fund	36
Oxford Science Enterprises	33
SOSV	33
Newable Private Investing	32
Cambridge Angels group	31
Oxford Capital	30
SyndicateRoom	30
Jonathan Milner	28
SFC Capital	26
IP Group	26
Northstar Ventures	25
Future Planet Capital	25
Octopus Ventures	24
Archangels	23
24 Haymarket	23
Kelvin Capital	23
Epidarex Capital	22
Ascension	22
Innovate UK	21
Techstart Ventures	21
Kindred Capital	21
GM&C Life Sciences Fund	21
Salica	20
Downing Ventures	20
Foresight Group	19
Hoxton Ventures	19
Midlands Engine Investment Fund	19
Calm/Storm Ventures	19
TRICAPITAL	18
Cambridge Innovation Capital	17
Praetura Ventures	16
Mercia Asset Management PLC	16
IQ Capital	16
Syncona Partners LLP	16
Midven	16
Seedcamp	15
M Ventures	15
Wellcome Trust	15
Meltwind Advisory	15

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
Antiverse — Designing biologics for 100 challenging targets
iFast Diagnostics — iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Investment focus

Biotechnology, Health Care, Software
Seed, Series A, Series B
United Kingdom, United States, Philippines

Portfolio highlights

Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Evoralis — Utilise Our Innovative Enzymes to Efficiently Recycle Plastics Into High-Quality Raw Materials
Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.

Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Series B
United Kingdom, United States, Finland

Portfolio highlights

natcap — We support the world's leading companies to prioritise, measure and act on nature impacts, dependencies, risks and opportunities.
FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
Iota Sciences — Discover automated single-cell handling tools and related services to accelerate your route to breakthrough discoveries in cell biology

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Investment focus

Biotechnology, Health Care, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

OxCan — Enabling curative cancer treatment through early detection
CryoLogyx — Assay Ready Cells - Discover CryoLogyx's advanced cryopreservation solutions, optimized for cell-based assays in drug discovery. Simply thaw with cell culture medium, and they are ready for use within 24 hours post-thaw.
Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!

Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Debt Financing
United Kingdom, Australia, United States

Portfolio highlights

Menna — Be smarter about money and grow faster with Menna. Take control of your business finances today!
Lineat Composites — We introduce a new aligned fibre material format that forms the basis of high-performance sustainable composite materials.
Llusern Scientific — Llusern specialises in rapid and affordable near-patient and POC molecular diagnostics developed to detect bacterial and viral infections.

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Investment focus

Biotechnology, Software, Health Care
Grant, Funding Round, Seed
United Kingdom, United States, Japan

Portfolio highlights

MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Australia, Singapore

Portfolio highlights

AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.
Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.
GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States, Hungary

Portfolio highlights

Kuano — Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
MGISS — Independently advising on the smarter use of Geospatial data, technology and the digital transformation of field operations.
Workbuzz — Give your Everyday Heroes a voice with employee surveys. Our flexible and simple survey platform reaches all employees, wherever they are. Book a demo now!

Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Investment focus

Software, Biotechnology, Health Care
Funding Round, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.

AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage B2B software and healthcare companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which isauthorised and regulated by the Financial Conduct Authority.

Investment focus

Software, Health Care, Information Technology
Series A, Funding Round, Seed
United Kingdom, United States, France

Portfolio highlights

Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
tem. — In a few simple steps we can manage your renewable energy needs forever.
Infact Systems — Infact Systems is a company that focuses on bringing affordability and credit information into the 21st century. They facilitate the sharing of real-time, contextual data, primarily in the banking industry. Their mission is to increase responsible financial behavior by providing real-time data for modern credit. They offer integration andcustomization services for HPZone, particularly in terms of connecting with external laboratory systems. Infact Systems also provides services to help women take control of their finances.

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
Anello Photonics — Anello Photonics is founded by pioneers in silicon photonics and inertial navigation. The patented Anello SiPhOG gyroscope offers an affordable mass-market sensor with true Optical Gyroscope performance. The company is headquartered in Silicon Valley and funded by leading venture capital firms.

BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Private Equity
United Kingdom, Ireland, United States

Portfolio highlights

Sulmara — Innovation for a sustainable energy future | Sulmara
Recite Me — Recite Me is an Accessibility Software & Solutions provider - helping to create WCAG compliant websites and inclusive experiences online for disabled people.
Miracle Design & Play — Miracle Design & Play specializes in designing and installing playgrounds for children.

Investment focus

Biotechnology, Health Care, Software
Series A, Seed, Series B
United Kingdom, United States, The Netherlands

Portfolio highlights

natcap — We support the world's leading companies to prioritise, measure and act on nature impacts, dependencies, risks and opportunities.
FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
Iota Sciences — Discover automated single-cell handling tools and related services to accelerate your route to breakthrough discoveries in cell biology

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States, Estonia

Portfolio highlights

xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
Qureight — Pioneering data curation to solve complex diseases
Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Ittybit — Ittybit is a API that enables users to handle rich media in applications. It provides developers with basic techniques for uploading, storing, transforming, and extracting data from video, music, and image files.
HealthKey — HealthKey is a platform that connects employers and insurers with health providers.
Noggin HQ — The next generation of credit referencing is coming. Look busy.

Our EIS and SEIS funds gives investors access to some of the UK's most promising startups. The Access EIS Fund co-invests with leading angel investors to build diversified portfolios based on data, while our SEIS fund lets investors back pre-seed B2B SaaS companies selected and fostered by leading fund Founders Factory.

Investment focus

Health Care, Software, Medical
Seed, Equity Crowdfunding, Funding Round
United Kingdom, United States, India

Portfolio highlights

Heatio — Heatio provides affordable renewable energy to homeowners.
Noggin HQ — The next generation of credit referencing is coming. Look busy.
Unibloom World — Unify targets with operational projects, make scenario simulations with cost impact in real time, compare new ideas, optimise actions and turn it into actionable projects with clear financial, regulations and business impact. Release burden from Sustainability Teams!

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Canada

Portfolio highlights

Clock Bio — Clock Bio operates as a biotech company, that develops novel regenerative medicines.
Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.
Exciting Instruments — Exciting Instruments Limited is a joint company founded in Sheffield that combines the software prowess of Bulldozer Limited with Dr. Timothy Craggs' knowledge of single molecules. Through the use of cloud connectivity and real-time data visualisation, we are a genuine science and software partnership on a mission to assist you in streamliningthe procedure for creating discoveries in biophysics, life sciences, drug discovery, and medical diagnostics.

Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.

Investment focus

Software, Artificial Intelligence, Information Technology
Pre-Seed, Seed, Funding Round
United Kingdom, United States, Canada

Portfolio highlights

LaennecAI — Empowering people to take control of their health
MAGIC AI — The home fitness system that uses AI technology to give you hyper-personalised training on demand on a beautifully designed mirror.
Chiron Health AI — Chiron supports people with self-managing their chronic conditions.

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Investment focus

Health Care, Biotechnology, Therapeutics
Seed, Series A, Series B
United Kingdom, United States, Australia

Portfolio highlights

Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.

Investment focus

Software, E-Commerce, SaaS
Seed, Funding Round, Series A
United Kingdom, United States, Indonesia

Portfolio highlights

FAT32 — FAT32 is at the forefront of compliance automation, transforming the way businesses satisfy regulatory requirements.
Lightox — Lightox has developed a unique range of molecular tools for use in imaging, therapeutics and assay development. These unique probes are smaller than any other commercially available fluorescent product. They offer the option of using our technologies as freely-moving probes that readily incorporate into cells or with a range of flexible linkers togive specificity to your unique applications and research needs.
Positive Support For You — Positive Support For You is a social enterprise dedicated to empowering adults with learning disabilities, providing tailored support to help them achieve greater independence, confidence, and inclusion in society.

Brilliant Ideas. Brilliant People. Brilliant Minds.

Investment focus

Biotechnology, Health Care, Software
Seed, Funding Round, Convertible Note
United Kingdom, United States, Canada

Portfolio highlights

Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
Antiverse — Designing biologics for 100 challenging targets
Wittaya Aqua — A better approach to aquaculture management

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Investment focus

Software, Health Care, Information Technology
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Cogna — Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains.
Cambri — Cambri is concept testing software that helps global brands accelerate their innovation process.
Forefront RF — Forefront RF tunable duplexer aims to expand the accessibility and global market reach of all mobile devices by simplifying RFFE design.

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Investment focus

Software, Biotechnology, Health Care
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
1inhaler — 1inhaler operates as a developer of drug delivery device.
iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Investment focus

Health Care, Software, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

myGwork — The global recruitment & networking hub for LGBTQ+ professionals. Find jobs in lesbian, gay, bisexual and transgender friendly organisations. Grow your LGBTQ+ professional network. Read the latest LGBTQ+ professional news.
Previsico — Previsico is a spinOut company from Loughborough University specialising in modelling flooding in real-time, using weather predictions to make street-level flood nowcasts and forecasts. The company's mission is to be the leading global provider of cutting-edge flood prediction that saves lives and livelihoods.Its FloodMap Live producesround the clock street-level flood risk predictions and analytics. Uniquely, these are continuously modelled and updated using a combination of different weather forecasts. This allows the company to map the likelihood of short and long-term surface water events in real-time to the street level.
Huq Industries — The leading monitoring platform for footfall, dwell, catchment and traffic flows valued by government, retail and real-estate. Used by 50+ councils!

We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors

Investment focus

Health Care, Biotechnology, Manufacturing
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Chromacity — Chromacity manufacture the next generation of ultrafast lasers. Discover our fixed wavelength femtosecond lasers and picosecond OPOs.
Biotangents — Biotangents develops veterinary diagnostic tests to detect infectious diseases in livestock (bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), brucellosis) using our highly adaptable molecular diagnostic technology, Moduleic Sensing.
Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Investment focus

Biotechnology, Therapeutics, Health Care
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.

Ascension is an early-stage VC built by exited entrepreneurs to back the next generation of tech and impact founders.Run by an experienced and diverse team of successful entrepreneurs, we have been relentlessly dedicated to finding the UK’s best Seed-stage startups since 2014.Ascension benefits from the active industry connections essential forthe sourcing and development of deal-flow and due diligence. The team has co-invested with the UK’s leading angels and VCs, key to securing follow-on funding as the portfolio businesses move to their next stage of growth.We believe in building an inclusive, community driven brand that can benefit the wider UK tech ecosystem and strive to work with conviction, integrity, humour, and humility.

Investment focus

Software, Internet, FinTech
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Italy

Portfolio highlights

MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
Linq — The safest way to send intimate content
Concert Bio — Concert Bio helps businesses manage their microbiome. We combine monitoring with analytics to develop interventions that improve the microbiome that matters to you. Our pilot program for CEA growers is currently live and accepting partners, see website for details.

Innovate UK is part of the UK Research and Innovation .

Investment focus

Health Care, Biotechnology, Software
Grant, Seed, Pre-Seed
United Kingdom, United States, Canada

Portfolio highlights

Tewke — Tewke is a London based company that was founded in 2020 developing technology to deliver energy savings through AI enabled home automation. Tewke's mission is to reduce energy consumption in homes whilst elevating everyone's living experience.Tewke's first product, Tap, is an intelligent light switch that can be installed into anyhome without rewiring. This acts as the backbone of Tewke's energy control and home automation platform, and has already won international awards, such as the Red Dot Design Award.
Chromatwist — ChromaTwist research and develop large Stokes Shift fluorescent dyes. The highly tunable technology is applicable for a broad range of applications.
Automated Architecture — A global ecosystem of automated micro-factories, to deliver sustainable, affordable and beautiful architecture to millions of people.

Techstart Ventures is a leading investor of seed capital across Scotland and Northern Ireland. they are a trusted partner to ambitious founders on their journey to success.

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Funding Round
United Kingdom, Ireland

Portfolio highlights

Needi — Needi is a retail company with an e-commerce platform specializing in gift shops. The company was founded in 2020 and is based in Manchester, United Kingdom.
INQDATA — INQDATA are a cloud-based data solutions provider who tranform the way financial institutions access and manage their market data. Our seamless integration makes it as easy as possible for clients to access the data they want, when they want it - all in their technology and tooling of choice.
Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
United Kingdom, Israel, United States

Portfolio highlights

Inversion — Inversion Space is a privately held company driven to change how humanity utilizes space. Its builds affordable, high cadence return vehicle for the commercial and defense industries.
Dunia Innovation — Catalysing the energy transition.
Civic Marketplace — Civic Marketplace is a platform that simplifies purchasing decisions, helps agencies make efficient, informed choices, and boosts local economic growth by providing access and opportunities to historically underutilized businesses.

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Italy, Germany

Portfolio highlights

ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.

Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.

Investment focus

Software, Health Care, Financial Services
Seed, Secondary Market, Series A
United Kingdom, United States, Germany

Portfolio highlights

Theremia — AI-driven platform to design drug derivatives with improved efficacy and tolerability across diverse demographics.
Neuphonic — Neuphonic is developing the best ultra low latency text-to-speech system to enable the most lifelike and responsive discussions with AI conceivable. We are transforming AI engagement by rethinking what it means to have a voice. We're building a future in which interacting with AI feels natural and seamless, AI can act to make people'slives easier, and people will look at their phones less and communicate more.
Popcorn AI — Popcorn is the smartest AI assistant to power your business. It helps you chat with customers, answer questions, sell products and collect payments.

The opportunity for institutional investors to access leading UK early stage healthtech businesses

Investment focus

Software, Health Care, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

TidalSense — CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath.
Qkine — Growth Factors made for stem cells Animal-free We control every step of protein manufacture ensuring all our products are completely animal-free Total transparency Stringent purity and bioactivity testing data for all proteins - know what you are giving your cells Protein innovation Our R&D team
FundamentalVR — A strategic partner helping med-device leaders solve the Competency @ Scale Gap todrive commercial success.

Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.

Investment focus

Software, Manufacturing, Health Care
Funding Round, Private Equity, Seed
United Kingdom, United States, Jersey

Portfolio highlights

TES Group — TES are engineering experts specialising in critical infrastructure. We provide specialist services to water & power industries worldwide.
Scorebuddy — All in one quality assurance call center software with automated tools for agent performance management, AI analytics and integrations. Try it free now!
Quality Food Products — Quality Food Products is a meat processing company that distributes meat products to various locations.

Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Series A, Funding Round
United Kingdom, United States, Canada

Portfolio highlights

Cogna — Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains.
Deblock — Forget your bank account: Get an IBAN, a Debit Card and a Non-custodial Crypto wallet. Deposit any crypto on your current account. Exchange Euro and Crypto without any limit.
PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.

MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local EnterprisePartnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.

Investment focus

Health Care, Manufacturing, Software
Debt Financing, Funding Round, Seed
United Kingdom, United States, Thailand

Portfolio highlights

Lexverify — Lexverify uses artificial intelligence to detect potential legal and compliance concerns in communications. It assists businesses in proactively avoiding legal and regulatory concerns by harnessing the power of AI. Their objective is to make technological communication a benefit rather than a problem.
Centaur Robotics — Centaur believes mobility needs re-imagining to provide a real advantage for everyday human needs. Our vision is to challenge thinking through design and technology to create superhuman technology - that provides extra-ordinary mobility fit for humans in the 21st Century.
Purple Transform — Purple Transform operates as an artificial intelligence company. Purple Transform improves decision accuracy with digital intelligence.

Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.

Investment focus

Health Care, Wellness, Software
Seed, Pre-Seed, Series A
Germany, United Kingdom, Austria

Portfolio highlights

PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
Linq — The safest way to send intimate content
Univa Health — Univa's objective is to provide evidence-based clinical tools that address the detrimental impact of eating disorder diseases on both the individual and their families.

The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series B
United Kingdom, France

Portfolio highlights

HonuWorx — HonuWorx is a technology company providing autonomous systems aimed at lowering both expenses and the environmental impact of operating robotic systems. The company's software technology is an edge-cloud architected communications and control platform that enables geographically distributed stakeholders to see data, collaborate, supervise, andcontrol robotic systems that are beyond line-of-sight.
Sellmyartworks — EzelDotz - Buy and Sell Contemporary Art Online | Art Marketplace. Curated collection of Sculptures, Limited Editions and Originals.
Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality

Cambridge Innovation Capital backs life sciences and technology companies with an affiliation to Cambridge, Europe’s capital for innovation. As a preferred investor for the University of Cambridge, they have unparalleled access to investment opportunities in the ecosystem.Since our inception in 2013, they have raised £275 million to invest indisruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, the internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health, and genomics/proteomics.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United Kingdom, United States, Ireland

Portfolio highlights

Forefront RF — Forefront RF tunable duplexer aims to expand the accessibility and global market reach of all mobile devices by simplifying RFFE design.
Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .

Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

Aquaint — Aquaint offers digital solutions for daily checklists, logs, spreedsheets, and related documentation.
North AI — North AI operates as an AI start up company for media sector.
Robotiz3d — Robotiz3d provide autonomous pothole detection, prevention, and repair technology. Designed for the cities of the future.

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Investment focus

Software, Information Technology, Manufacturing
Funding Round, Series A, Seed
United Kingdom, United States

Portfolio highlights

Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
Axis Spine Technologies — Axis Spine Technologies is building an expert team to develop highly differentiated products that provide meaningful improvements in patient care.
Send — Streamline the underwriting process with Send's innovative commercial insurance platform. Our underwriting workbench is designed to automate time-consuming manual tasks so you can focus more on data-driven underwriting.

IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Series A, Funding Round
United Kingdom, United States, The Netherlands

Portfolio highlights

Molyon — Molyon is creating the next-generation energy storage system: the lithium-sulfer battery. Molyon offers long-life lithium-sulfur batteries that have twice the energy density of existing lithium-ion batteries on the market.
Vsim Technology — Experience the power of next-generation physics simulations with Vsim. Our cutting-edge technology provides realistic and accurate simulations for various industries.
BMLL Technologies — BMLL Technologies Ltd. operates cloud based technology platform that offers machine learning and inference framework for common limit order book problems.

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Seed
United Kingdom, United States, Switzerland

Portfolio highlights

iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
Purespring Therapeutics — Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally.
Resolution Therapeutics — Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Midven is a specialist venture capital company providing investment to fast growing small and medium sized enterprises ("SMEs"), run by an energetic, experienced and hands-on team of investment managers.

Investment focus

Software, Manufacturing, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

Lexverify — Lexverify uses artificial intelligence to detect potential legal and compliance concerns in communications. It assists businesses in proactively avoiding legal and regulatory concerns by harnessing the power of AI. Their objective is to make technological communication a benefit rather than a problem.
Nylahs Naturals — Shop our award-winning all-natural hair care products, designed to redefine the haircare standard for afro-textured hair.
Strolll — Strolll Neurotechnology

Seedcamp is Europe's seed fund, identifying and investing early in world-class founders attacking large, global markets and solving real problems using technology. The Seedcamp Nation includes over 400 startups building breakout businesses that change the way people live, interact and buy and includes publicly listed UiPath, Wise, and unicornsRevolut, Hopin, Sorare, Pleo, and wefox along with fast-growing businesses such as Grover, viz.ai and Ezra. Seedcamp fast-tracks a founder's vision and creates value through immediate access to smart capital, a lifelong community of support and a global network built upon more than a decade's experience backing exceptional talent.Seedcamp fast-tracks a founder's vision and creates value through immediate access to smart capital, a lifelong community of support, and a global network built upon more than a decade's experience backing exceptional talent.

Investment focus

Software, FinTech, SaaS
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Sylvera — Sylvera Carbon offset ratings make offset quality and risks transparent. We make offsets auditable for offset sellers, intermediaries, buyers and investors.
Outverse — A community platform that's easier to use, better organised and designed for real interaction.
Dust — Dust is a platform for creating sophisticated processes based on large language models and semantic search.

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Switzerland, United Kingdom

Portfolio highlights

Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
Formo — We're Formo, the future of dairy. Using micro fermentation, we create animal-free cheeses that humans love.
NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Grant, Series C, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Meltwind Advisory.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
Infinitopes — Infinitopes is a cancer research organization whose mission is to strengthen the immune system so that it can stop metastases and save lives. The company's platform creates healthcare systems and therapy designs to integrate high-efficiency vector delivery systems with optimal tumor target identification technologies in early-stage clinicaltrials, allowing patients to prevent cancer and tumors from taking their lives
Shift Bioscience — Explore cutting-edge simulation-guided cell rejuvenation techniques aimed at combating aging-related diseases.

Investors by industry

Artificial intelligence